advertisement
Lin H 19
Showing records 1 to 19 | Display all abstracts from Lin H117146 Anterior chamber proliferative membrane interception (AC-PMI)-enhanced trabeculectomy versus trabeculectomy for treating neovascular glaucoma: protocol for a randomized controlled trial
Zhu S
Trials 2024; 25: 287
117369 Patient satisfaction and follow-up adherence to glaucoma case management clinic in China
Lin H
International Journal of Ophthalmology 2024; 17: 73-81
117017 Trends in admission rates of primary angle closure diseases for the urban population in China, 2011-2021
Chen Q; Shen P
Frontiers in public health 2024; 12: 1398674
117369 Patient satisfaction and follow-up adherence to glaucoma case management clinic in China
Lu HJ
International Journal of Ophthalmology 2024; 17: 73-81
117146 Anterior chamber proliferative membrane interception (AC-PMI)-enhanced trabeculectomy versus trabeculectomy for treating neovascular glaucoma: protocol for a randomized controlled trial
Zhou M
Trials 2024; 25: 287
117017 Trends in admission rates of primary angle closure diseases for the urban population in China, 2011-2021
Zhou M
Frontiers in public health 2024; 12: 1398674
117146 Anterior chamber proliferative membrane interception (AC-PMI)-enhanced trabeculectomy versus trabeculectomy for treating neovascular glaucoma: protocol for a randomized controlled trial
Li H
Trials 2024; 25: 287
117369 Patient satisfaction and follow-up adherence to glaucoma case management clinic in China
Zhou WZ
International Journal of Ophthalmology 2024; 17: 73-81
117017 Trends in admission rates of primary angle closure diseases for the urban population in China, 2011-2021
Cao Y
Frontiers in public health 2024; 12: 1398674
117369 Patient satisfaction and follow-up adherence to glaucoma case management clinic in China
Zuo SS
International Journal of Ophthalmology 2024; 17: 73-81
117146 Anterior chamber proliferative membrane interception (AC-PMI)-enhanced trabeculectomy versus trabeculectomy for treating neovascular glaucoma: protocol for a randomized controlled trial
Zhang S; Xu S
Trials 2024; 25: 287
117017 Trends in admission rates of primary angle closure diseases for the urban population in China, 2011-2021
Zheng X
Frontiers in public health 2024; 12: 1398674
117369 Patient satisfaction and follow-up adherence to glaucoma case management clinic in China
Chen YY
International Journal of Ophthalmology 2024; 17: 73-81
117017 Trends in admission rates of primary angle closure diseases for the urban population in China, 2011-2021
Zhao F
Frontiers in public health 2024; 12: 1398674
117369 Patient satisfaction and follow-up adherence to glaucoma case management clinic in China
Zhang SD
International Journal of Ophthalmology 2024; 17: 73-81
117146 Anterior chamber proliferative membrane interception (AC-PMI)-enhanced trabeculectomy versus trabeculectomy for treating neovascular glaucoma: protocol for a randomized controlled trial
Lin H; Xie Y
Trials 2024; 25: 287
117017 Trends in admission rates of primary angle closure diseases for the urban population in China, 2011-2021
Ding Y
Frontiers in public health 2024; 12: 1398674
117146 Anterior chamber proliferative membrane interception (AC-PMI)-enhanced trabeculectomy versus trabeculectomy for treating neovascular glaucoma: protocol for a randomized controlled trial
Le R; Liang Y
Trials 2024; 25: 287
117017 Trends in admission rates of primary angle closure diseases for the urban population in China, 2011-2021
Ji Y; Zuo J; Lin H; Liang Y
Frontiers in public health 2024; 12: 1398674
